Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.

DOI10.1073/pnas.86.9.3003zbMath0665.62108OpenAlexW2071990407WikidataQ33851860 ScholiaQ33851860MaRDI QIDQ3816886

Cun-Hui Zhang

Publication date: 1989

Published in: Proceedings of the National Academy of Sciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1073/pnas.86.9.3003

zbMATH Keywords

clinical trialsu,v methoddrug testingestimation under biased sampling

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (8)

Efficiency of the u,v method of estimation ⋮ Estimation of sums of random variables: examples and information bounds ⋮ ``Waiting for life to arrive: a history of the regression-discontinuity design in psychology, statistics and economics ⋮ Compound decision theory and empirical Bayes methods ⋮ Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients. ⋮ Estimating a multivariate treatment effect under a biased allocation rule ⋮ Tests of odds ratio homogeneity with improved power in sparse fourfold tables ⋮ Mathematical aspects of estimating two treatment effects and a common variance in an assured allocation design

This page was built for publication: Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.